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Early involvement of gut is observed in Parkinson’s Disease (PD) and symptoms, such as gastrointestinal 
dysmotility, and digestive disorders, may precede motor ones. [1] A recent study demonstrated the link 
between gut microbiota alteration in PD patients and a reduction of bacteria producing short chain fatty acids 
(SCFAs). [2] Among these, butyrate has been shown to improve motor functions when administered in PD 
animals; moreover, it exerts beneficial effects in the gut, reducing inflammation, improving gut integrity, 
visceral sensitivity and intestinal motility. Here, we investigated whether antibiotic-induced gut alterations are 
involved in worsening PD symptoms and the effects of sodium butyrate (BuNa) in modulating brain and gut 
bidirectional interplay. In order to induce gut microbiota dysbiosis, mice were treated with ceftriaxone (CFX, 
8 g/kg, per os) for 5 days; [3] afterwards mice were injected with 6-hydroxydopamine (6-OHDA, 4 µ g/2µ l) in 
the right striatum. [4] Mice challenged with 6-OHDA or with CFX and 6-OHDA were treated with BuNa (100 
mg/kg os) once daily for 14 days. Here, we demonstrated the worsening effects of CFX administration in PD 
pattern and BuNa capability in improving motor deficit in both 6-OHDA and 6-OHDA+CFX mice. These 
behavioural motor effects were related to BuNa-induced reduction of inflammatory, oxidative and apoptotic 
parameters at striatal level. Moreover, we demonstrated that BuNa improved colonic inflammation and 
integrity altered by both CFX and/or 6-OHDA, which mirrored the reduction of serum inflammatory mediators. 
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